STAA — STAAR Surgical Company stock price and chart

STAA

$22.32+2.01%

as of close, Oct 20, 2026

☾ AH $22.32 +2.01%

STAAR Surgical CompanyStock · HealthcareRussell 2000 · 0.03% of IWMRussell 3000 · 0.002% of IWVUS Stock Market · 0.001% of VTI

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEEE

20162019202120242026

20.040.060.080.0100.0120.0140.0020.0M40.0M$22.32

2026-10-20

Price$22.32

MA20$25.40

MA50$24.32

Vol2.6M

What would $1,000 invested in STAA be worth today? →

STAA returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $22.32
YTD price return: -3.33%
YTD total return: -3.33%
Next earnings: Nov 4, 2026
Market cap: 1.1B2016-12 442.1M2026-10 1.1B+153.2% over the window
Enterprise value: 973.7M
Shares outstanding: 50.1M2016-07 40.4M2026-07 50.1M+24.0% over the window
52W low: $15.59
52W high: $35.87
From 52W high: -37.78%
From 52W low: +43.17%
52W range: 33%

Volume

Rel volume: 0.67×
30D volume: 923.3K
30D $ vol: 20M

Fundamentals

Sales (ttm): 339.6M2016-07 79.9M2026-07 339.6M+325.3% over the window
Sales/share: $6.772016-07 $1.972026-07 $6.77+242.9% over the window
EPS (ttm): $0.082016-09 -$0.322026-07 $0.08-124.0% over the window
FCF (ttm): -6.7M2016-07 -4.6M2026-07 -6.7M+48.0% over the window
FCF/share: -$0.132016-07 -$0.112026-07 -$0.13+19.3% over the window
Book value/share: $7.292016-07 $0.942026-07 $7.29+675.6% over the window
Net margin: 1.13%2016-07 -16.0%2026-07 1.1%-107.1% over the window
ROE: 1.05%2016-07 -33.6%2026-07 1.1%-103.1% over the window
ROA: 0.81%2016-07 -19.6%2026-07 0.8%-104.1% over the window
Current ratio: 4.662016-07 2.402026-07 4.66+94.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +50.33%2025-06-27 → 2026-07-03224.4M → 339.6M (+51.3% total)+9.37%2023-09-29 → 2026-07-03265.2M → 339.6M (+28.0% total)+10.49%2021-07-02 → 2026-07-03206.2M → 339.6M (+64.7% total)+15.57%2016-07-01 → 2026-07-0379.9M → 339.6M (+325.3% total)
Net income: n/a-45.36%2023-09-29 → 2026-07-0320.4M → 3.8M (-81.1% total)-28.65%2021-07-02 → 2026-07-0320.8M → 3.8M (-81.5% total)n/a
Shares: +1.17%2025-06-27 → 2026-07-0349.6M → 50.1M (+1.2% total)+0.98%2023-09-29 → 2026-07-0348.8M → 50.1M (+2.7% total)+1.13%2021-07-02 → 2026-07-0347.4M → 50.1M (+5.8% total)+2.18%2016-07-01 → 2026-07-0340.4M → 50.1M (+24.0% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: n/a-45.83%2023-09-29 → 2026-07-03$0.41 → $0.08 (-81.6% total)-28.99%2021-07-02 → 2026-07-03$0.42 → $0.08 (-82.0% total)n/a
Sales/share: +48.59%2025-06-27 → 2026-07-03$4.53 → $6.77 (+49.5% total)+8.31%2023-09-29 → 2026-07-03$5.43 → $6.77 (+24.6% total)+9.25%2021-07-02 → 2026-07-03$4.35 → $6.77 (+55.7% total)+13.11%2016-07-01 → 2026-07-03$1.97 → $6.77 (+242.9% total)
Book value/share: +7.17%2025-06-27 → 2026-07-03$6.79 → $7.29 (+7.3% total)-2.23%2023-09-29 → 2026-07-03$7.76 → $7.29 (-6.0% total)+8.04%2021-07-02 → 2026-07-03$4.95 → $7.29 (+47.2% total)+22.72%2016-07-01 → 2026-07-03$0.94 → $7.29 (+675.6% total)
Price: -11.86%2025-10-20 → 2026-10-20$25.32 → $22.32 (-11.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-18.82%2023-10-20 → 2026-10-20$41.72 → $22.32 (-46.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-29.24%2021-10-20 → 2026-10-20$125.83 → $22.32 (-82.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.97%2016-10-19 → 2026-10-20$9.45 → $22.32 (+136.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -11.86%2025-10-20 → 2026-10-20$25.32 → $22.32 (-11.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-18.82%2023-10-20 → 2026-10-20$41.72 → $22.32 (-46.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-29.24%2021-10-20 → 2026-10-20$125.83 → $22.32 (-82.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+8.97%2016-10-19 → 2026-10-20$9.45 → $22.32 (+136.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 294.7×2016-12 -36.452026-10 291.54-899.8% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 81.5×2016-12 -34.942026-10 81.50-333.3% over the window
Fwd P/E: 19.7×
P/S (ttm)Market cap ÷ TTM revenue.: 3.3×2016-12 5.362026-10 3.30-38.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 3.1×2016-12 11.662026-10 3.06-73.7% over the window
EV/EBITDA (fy): 43.8×
EV/Sales (ttm): 2.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -0.60%2016-09 -1.0%2026-07 -0.5%-52.5% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-07-03) ÷ shares_at(2025-06-27) = 1 − 50.1M ÷ 49.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.17%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.17%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-27) ($838.4M). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.17%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($2M) ÷ today's market cap ($1.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.18%2016-09 0.0%2026-07 0.1%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $2M + TTM dividends $0) ÷ today's market cap ($1.1B). Same caveat as the cash buyback yield.: 0.18%2016-09 0.0%2026-07 0.1%

Vs own 10Y history

P/E: 66th
P/OI: 25th
P/S: 4th
P/B: 10th
P/FCF: 0th

Bar = where today’s multiple sits in STAA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.01%

+3.81%

+7.20%

-6.88%

YTD

-3.33%

-11.85%

-82.26%

Financial statements

Open full STAA financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

STAA — STAAR Surgical Company price, chart and key statistics